ASRC Press Releases

Natural Factors Discontinues Certain Claims for ‘Theracurmin’ in Response to NAD Inquiry; NAD Recommends Additional Modifications

The NAD has recommended that Natural Factors, Inc., modify or discontinue certain claims for the company’s Theracurmin line of curcumin dietary supplements. Following its review of the company’s advertising, NAD determined that the company could support certain claims.

Read More

Xenex Discontinues Claims for ‘Germ-Zapping Robots’ Following NAD Inquiry; Claims at Issue – Including Ebola Disinfectant Claims – Challenged by Clorox

Xenex Disinfection Services LLC has said it has either discontinued or will discontinue certain advertising claims for the company’s “Germ-Zapping Robots.” The claims were challenged before the National Advertising Division by The Clorox Company.

Read More

CARU Recommends Bandai Modify Broadcast Advertising for Tamagotchi

CARU has recommended that Bandai America Inc., modify broadcast advertising for the company’s “Tamagotchi” toys to ” to adequately disclose that batteries are not included.

Read More

NAD Recommends Sprint Discontinue ‘New’ Network, Customer Satisfaction Claims, Following T-Mobile Challenge

The NAD has recommended that Sprint Corporation discontinue advertising claims that reference a “brand new,” “all-new” or “America’s Newest” network. Further, NAD has recommended that Sprint discontinue claims that the company “is the most improved U.S. company in customer satisfaction, across all 43 industries, over the last six years.”

Read More

CARU Examines Boy Scouts Sweepstakes Advertising, Recommends Modifications

CARU has recommended that Boy Scouts of America (BSA) modify advertising for the “Boys Life Cybersearch Sweepstakes” to more clearly identify the odds of winning a $100 grand prize.

Read More

NAD Recommends Genomma Lab Discontinue Challenged Claims in Spanish-Language Ad for Antibiotic Ointment

The NAD has recommended that Genomma Lab USA, Inc., discontinue challenged claims made in Spanish-language broadcast advertising for La Pomada de la Compana triple antibiotic ointment. The claims at issue were challenged by Vitacilina Corporation of America, a competing maker of antibiotic ointment.

Read More